First Commonwealth Financial’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$594K Buy
1,136
+1
+0.1% +$512 0.08% 168
2026
Q2
$564K Hold
1,135
– – 0.08% 185
2026
Q1
$507K Buy
1,135
+1
+0.1% +$466 0.08% 178
2025
Q4
$514K Sell
1,134
-1
-0.1% -$431 0.08% 173
2025
Q3
$444K Sell
1,135
-67
-6% -$28K 0.07% 186
2025
Q2
$535K Hold
1,202
– – 0.12% 152
2025
Q1
$583K Buy
1,202
+677
+129% +$315K 0.14% 142
2024
Q4
$211K Buy
+525
New +$243K 0.05% 208

Other funds holding VRTX

First Commonwealth Financial's VRTX Position: Q3 2026 in Review

First Commonwealth Financial increased its Vertex Pharmaceuticals (VRTX) stake by 0.09% in Q3 2026, buying an estimated $512 and bringing the position to 1,136 shares worth $594K. The position accounts for 0.08% of the portfolio, ranked #168.

First Commonwealth Financial first reported a position in VRTX in Q4 2024 and has held it in 8 quarters since. 1,556 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • First Commonwealth Financial held 1,136 shares of Vertex Pharmaceuticals worth $594K as of Q3 2026.
  • First Commonwealth Financial bought 1 Vertex Pharmaceuticals share in Q3 2026, an estimated $512.
  • Vertex Pharmaceuticals made up 0.08% of First Commonwealth Financial's portfolio in Q3 2026, its #168 holding.
  • First Commonwealth Financial first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
  • 1,556 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on First Commonwealth Financial's 13F filing for Q3 2026, filed 13 Nov 2026.